3 TO 5 years to go. 30-50 million revenue by then. P/E of 10 would put the companys value at 300-500million. current value 200million. 50-150% increase in this 3-5 years still worth holding IMO
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
